Cutaneous respirometry as novel technique to monitor mitochondrial function: A feasibility study in healthy volunteers by Harms, F.A. (Floor A.) et al.
RESEARCH ARTICLE
Cutaneous Respirometry as Novel Technique
to Monitor Mitochondrial Function: A
Feasibility Study in Healthy Volunteers
Floor Harms1*, Robert Jan Stolker1, Egbert Mik1,2
1 Department of Anesthesiology, Laboratory of Experimental Anesthesiology, Erasmus University Medical
Center Rotterdam, ‘s-Gravendijkwal 230, 3015 CERotterdam, The Netherlands, 2 Department of Intensive Care,
Erasmus University Medical Center Rotterdam, ‘s-Gravendijkwal 230, 3015 CERotterdam, The Netherlands
* f.harms@erasmusmc.nl
Abstract
Background
The protoporphyrin IX-triplet state lifetime technique (PpIX-TSLT) is proposed as a potential
clinical non-invasive tool to monitor mitochondrial function. This technique has been evalu-
ated in several animal studies. Mitochondrial respirometry allows measurement in vivo of
mitochondrial oxygen tension (mitoPO2) and mitochondrial oxygen consumption (mitoVO2)
in skin. This study describes the first use of a clinical prototype in skin of humans.
Methods
The clinical prototype was tested in 30 healthy volunteers. A self-adhesive patch containing
2 mg 5-aminolevulinic acid (ALA) was applied on the skin of the anterior chest wall (sternal)
for induction of mitochondrial protoporphyrin IX and was protected from light for 5 h.
MitoPO2 was measured by means of oxygen-dependent delayed fluorescence of protopor-
phyrin IX. MitoVO2 was determined by dynamic mitoPO2 measurements on the primed
skin, while locally blocking oxygen supply by applying local pressure with the measurement
probe. MitoPO2 was recorded before and during a 60-s period of compression of the micro-
circulation, at an interval of 1 Hz. Oxygen consumption (i.e. the local oxygen disappearance
rate) was calculated from the decay of the mitoPO2 slope.
Results
Oxygen-dependent delayed fluorescence measurements were successfully performed in
the skin of 27 volunteers. The average value (± SD) of mitoPO2 was 44 ± 17 mmHg and
mean mitoVO2 values were 5.8 ± 2.3 and 6.1 ± 1.6 mmHg s
-1 at a skin temperature of 34°C
and 40°C, respectively. No major discomfort during measurement and no long-term derma-
tological abnormalities were reported in a survey performed 1 month after measurements.
Conclusion
These results show that the clinical prototype allows measurement of mitochondrial oxygen-
ation and oxygen consumption in humans. The development of this clinically applicable
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Introduction
An adequate supply of oxygen to tissue and its subsequent use in oxidative phosphorylation in
the mitochondria is essential for preserving cellular integrity and, ultimately, life. Therefore, a
non-invasive and in vivomonitoring system able to monitor mitochondrial parameters, like
oxygenation and oxygen consumption, could be a valuable tool for clinicians [1].
The most common ex vivo techniques are oxygen consumption measurements using oxygen
electrodes [2], such as high-resolution respirometry [3]. These ex vivo techniques measure in
suspensions of isolated cells and mitochondria, or small tissue biopsies and may, therefore, not
adequately reflect the in vivo situation. Another method, the XF24 Extracellular Flux Analyze
(Seahorse Bioscience) [4, 5] allows ex vivomeasuring of mitochondrial oxygen consumption in
intact cells or tissue by oxygen-sensing fluorophores. Although these approaches provide
highly specific information on the function of the mitochondrial respiratory chain, the ex vivo
use is a well-recognized limitation [6]. Ex vivo techniques are incapable for bed-side montoring
and determination of mitochondrial function under physiological or pathophysiological cir-
cumstances is essential to understand and evaluate changes in oxidative phosphorylation [7].
To overcome limitations of ex vivo approaches, numerous in vivo techniques have been
used to study mitochondrial function within the context of the physiological environment.
Most commonly used methods to measure mitochondrial function in vivo are Nuclear Mag-
netic Resonance (NMR) spectroscopy and near-infrared spectroscopy (NIRS). NMR spectros-
copy measures changes in phosphormetabolites to determine rates of resting and maximal
mitochondrial ATP production. Unfortunately, the need of a Magnetic Resonance Imaging
(MRI) scan makes NMR spectroscopy expensive and unable for bed-side monitoring. In con-
trast, NIRS enables bedside monitoring of mitochondrial function by continuous monitoring
of variations in hemoglobin oxygenation and in the redox state of cytochrome c oxidase. A new
application of NIRS allows measurement of skeletal muscle oxidative capacity by following the
change in the rate of oxygen consumption during recovery from ischemia or exercise [8–10].
Unfortunately, recovery of the cytochrome oxidase signal from NIRS data remains controver-
sial [11]. NIRS is influenced by tissue-specific effects, such as the wavelength dependence of
the optical path length and changes in light scattering [12, 13].
Indirect calorimetry is the current golden standard for examining respiration in vivo. This
technique measures inspired and expired gas flows, volumes and concentrations of oxygen
(O2) and carbon dioxide (CO2), and allows measurement of total body oxygen consumption
(VO2). Also Fick’s principle has been applied in humans for many years to measure VO2 by
combining data of regional blood flow and arterial-venous oxygen content difference. How-
ever, both measurements can generate data with a high variability and, therefore, its use for
clinical decision-making has been questioned [14, 15].
The protoporphyrin IX-triplet state lifetime technique (PpIX-TSLT) is proposed as a poten-
tial novel approach to determine mitochondrial oxygen consumption [16]. The first detailed
description of the PpIX-TSLT was published in 2006 [17]. PpIX-TSLT enables mitochondrial
oxygen (mitoPO2) measurements by means of the oxygen-dependent optical properties of pro-
toporphyrin IX (PpIX). PpIX-TSLT was the first technique to allow measurements of mitoPO2
in living cells and can be applied in vivo [18–20]. Our group has been working on the develop-
ment of PpIX-TSLT from its use in cell cultures to a monitoring system of mitochondrial
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function in humans [21]. This technique has been tested and calibrated for use on isolated
organs [19, 20] and in vivo [20]. Subsequently, oxygen-dependent quenching of delayed fluo-
rescence of PpIX has been observed in skin [18] and validation of the quenching constants
needed to calculate mitoPO2 from the signals has been successful [22]. In addition to direct
non-invasive measurement of mitoPO2, it is also technically possible to gain information on
mitochondrial function. Information on mitochondrial oxygen consumption (mitoVO2) can
be obtained by dynamic mitoPO2 measurements while blocking local oxygen supply. The local
oxygen disappearance rate is a measure of oxygen consumption and can be calculated from the
decay of the mitoPO2 [23]. As proposed earlier [18, 22–26], it should be technically possible
and safe to apply PpIX-TSLT in humans.
In the present study, we demonstrate for the first time the ability to measure mitoPO2 and
mitoVO2 in human skin, using a clinical prototype of PpIX-TSLT. The safety and feasibility of
our method is investigated and data are presented on the inter- and intra-individual distribu-
tion of mitochondrial oxygen measurements. Our ultimate goal is to develop the PpIX-TSLT
as a non-invasive monitor that allows direct assessment of mitochondrial oxygenation and
(dys)function in critically ill patients. Although mitochondrial dysfunctions are thought to be
related to the pathogenesis of sepsis and multiorgan failure [26–28], inconsistent data have
been reported. These conflicting results may be due to the wide variety of methods used to
determine mitochondrial dysfunction in sepsis [1]. Therefore, a standard method to monitor
mitochondrial dysfunction could further elucidate the role of the mitochondria during septic
conditions. When the PpIX-TSLT has proven to do this successfully, opportunities will arise
for novel strategies in the treatment of severe sepsis.
Methods
The study was performed in compliance with the Code of Ethics of the World Medical Associa-
tion (Declaration of Helsinki) and approved by the Institutional Review Board at the Erasmus
MC CCMO-register NL37911.078.11). A total of 30 volunteers were drawn from a pool of
young, healthy students and hospital staff aged 18–30 years. Written informed consent was
obtained from all volunteers prior to study participation.
Principle of mitoPO2 measurements
The background of the PpIX-TSLT is described in detail elsewhere [17, 20]. In short, PpIX is
the final precursor of heme in the heme biosynthetic pathway. PpIX is synthesized in the mito-
chondria, and administration of 5-aminolevulinic acid (ALA) substantially enhances the PpIX
concentration. PpIX possesses a triplet state that reacts strongly with oxygen, making its life-
time oxygen-dependent. Population of the first excited triplet state occurs upon photo-excita-
tion with a pulse of light, and causes the emission of red delayed fluorescence. The delayed
fluorescence lifetime is related to mitoPO2 according to the Stern-Volmer equation:
mitoPO2 ¼ ð1=t 1=t0Þ=kq ð1Þ
in which τ is the measured delayed ﬂuorescence lifetime, kq is the quenching constant and τ0 is
the lifetime at zero oxygen. Eq 1 is valid for a homogenous oxygen distribution and after excita-
tion with a pulse of light of which the lifetime is much shorter than τ [29]. In case of a non-
homogenous oxygen distribution inside the measurement volume, a reliable estimation of the
average PO2 can be made by the rectangular distribution method (RDM) [30, 31].
The signal/noise ratio (SNR) of resulting traces was calculated and defined as the ratio of
maximum signal amplitude to the peak-to-peak noise. Lifetime analysis operates stably at
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moderate SNR (SNR>20) [20]. Therefore, only delayed fluorescence signals with a SNR>20
were analyzed and included in the present dataset.
Principle of mitoVO2 measurements
MitoVO2 is measured by means of the oxygen disappearance rate (ODR) after local occlusion
of the oxygen supply. Local occlusion of the microcirculation in skin was obtained by applica-
tion of pressure with the measurement probe. This simple procedure created reliable stop-flow
conditions and induced measurable oxygen disappearance rates, due to cessation of microvas-
cular oxygen supply and ongoing cellular oxygen consumption. MitoPO2 was measured before
and during application of pressure at an interval of 1 Hz, using 4 laser pulses per measurement.
We have described the basic principles behind the technology and have provided a working
implementation of the technique for mitoVO2 measurements (15) as well as a method to calcu-
late mitoVO2. Fig 1 presents an example of the analysis of mitoVO2.
Experimental setup
Prior to oxygen measurements the heart rate, blood pressure and peripheral oxygen saturation
were determined in all volunteers, and a standard preoperative evaluation form was obtained
from all these participants.
Oxygen measurements were performed by means of a clinical prototype PpIX-TSLT device
[24]. A self-adhesive patch containing 8 mg ALA (Alacare1; Spirig AG, Egerkingen, Switzer-
land) was applied on the skin of the anterior chest wall (sternal), for induction of PpIX. To
enhance ALA penetration adequate skin preparation proved essential. Hair was shaved (if pres-
ent) and the skin was rubbed with a fine abrasive pad of a standard ECG sticker to remove the
Fig 1. Principle of respirometry by local cessation of the oxygen supply.Mitochondrial oxygen
consumption (mitoVO2) is calculated from the linear part of the oxygen disappearance curve following local
compression of the microcirculation by the measurement probe.
doi:10.1371/journal.pone.0159544.g001
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top parts of the stratum corneum. After ALA application, the skin was protected from light for
5 h. During these 5 h a suitable concentration of PpIX was synthesized to enable measurements
of mitoPO2 and mitoVO2. To minimize the influence from ambient light, the experiments
were performed in dimmed light. First, three successive mitoPO2 measurements were per-
formed during a period of 90 s under baseline conditions. Subsequently, mitoVO2 was deter-
mined with a heated measurement probe at 34°C and 40°C. Warming of the measurement
probe was done to prevent local vasoconstriction due to a cold probe, and to eliminate the
effect of differences in skin temperature on the measurements. The temperature of 34°C was
chosen because this was the maximal skin temperature determined in 10 healthy volunteers in
a normal environment, measured by infrared thermography. To determine the effect of hyper-
thermia on mitoVO2 a probe temperature of 40°C was chosen. This temperature was well
above the mean skin temperature [32] and low enough not to induce skin burns. One month
after the experiments an evaluation form was completed by all volunteers. The form consisted
of questions about any pain during the measurements and the appearance of dermatological
symptoms, such as erythema, pruritus and hyperpigmentation of the skin.
Statistical analysis
Unless stated otherwise, reported values are mean ± SD. Normality of the data was tested using
the Shapiro-Wilk test. Correlation between the two variables was tested by Pearson's correla-
tion analysis.
Results
Basic characteristics of the 30 healthy volunteers are shown in Table 1. All participants had
normal results for the physical parameters, such as heart rate, blood pressure and arterial oxy-
gen saturation. Due to insufficient signal-to-noise ratio the measurements of three volunteers
were excluded from further analysis.
MitoPO2 Measurements
A typical example of a baseline mitoPO2 measurement is presented in Fig 2A. Due to the het-
erogeneous oxygenation in the skin a marked intra-individual variation was observed during
the baseline measurement due to movement (breathing) in combination with a small measur-
ing area (the diameter of the detection fiber was only 1 mm). Therefore, the mean mitoPO2
(red line) over a period of 90 s was used in the analysis of mitoPO2.
From the total of 27 experiments, mean mitoPO2 was 44 ± 17 mmHg (Fig 2B). This finding
is consistent with previous values derived from animal studies [21, 33]. Despite the movement-
Table 1. Characteristics healthy volunteers.
Characteristics Volunteers (n = 30)
Age (years) 26 ± 5
Sex, n (%)
Men 19 (63)
Women 11 (37)
Heart rate (bpm ± SD) 69 ± 13
Systolic blood pressure (mmHg ± SD) 128 ± 12
Diastolic blood pressure (mmHg ± SD) 76 ± 10
Arterial saturation (% ± SD) 99 ± 1
doi:10.1371/journal.pone.0159544.t001
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induced variation in baseline mitoPO2, the mean data regress towards a normal distribution
(p = 0.73; skewness = 0.07 ± 0.45, kurtosis = -0.46 ± 0.87) (Fig 2C).
MitoVO2 Measurements
A typical example of an oxygen disappearance curve on human skin is presented in Fig 3A.
The mean mitoVO2 values, measured in the skin of 27 healthy volunteers, were 5.8 ± 2.3 and
6.1 ± 1.6 mmHg s-1 for a probe temperature of 34°C and 40°C, respectively (Fig 3B). The distri-
bution of the data is presented in Fig 3C. The Shapiro-Wilk test demonstrates that mitoVO2
measured at a temperature of 34°C follows a normal distribution (p-value = 0.069, skew-
ness = 0.9, kurtosis = 1.9). However, the same analysis of mitoVO2 at a temperature of 40°C
does not follow a normal distribution (p-value = 0.047, skewness = 0.72 ± 0.45, kurtosis =
-0.29 ± 0.87).
Correlation between mitoPO2 and mitoVO2
We found a weak positive correlation between mitoVO2 and baseline mitoPO2 for 27 data
pairs (Fig 4). This indicates that mitoVO2 of the skin might not be completely independent of
baseline mitoPO2 levels. However, the correlation is mainly caused by very high and/or very
low mitoPO2 values.
Safety of the measurements
All healthy volunteers experienced the skin preparation and measurements as non-problem-
atic. Due to either the skin preparation or the ALA patch, 45% of the volunteers suffered from
mild pruritus and/or erythema on the actual measurement day; these minor complaints were
no longer present the day after the measurements. Only two volunteers had transient hyperpig-
mentation of the skin after the measurements, possibly due to premature exposure of the
primed area to sunlight (against our advice). The hyperpigmentation was temporary and disap-
peared within one month. None of the volunteers sustained long-term skin damage, as estab-
lished one month after the experiments.
Discussion
This study presents the first results of a clinical prototype of a novel non-invasive monitoring
device based on PpIX-TSLT. This device enables measurement of mitochondrial oxygenation
Fig 2. A. Example of a baseline mitoPO2 measurement. The mean mitochondrial oxygen tension (mitoPO2) (red line) is calculated over a period of 90
second.B. The mitoPO2 is presented in a box-and-whisker graph,C. Frequency distribution of all ratio differences of the mitoPO2.
doi:10.1371/journal.pone.0159544.g002
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Fig 3. A. Typical example of the analysis of the mitochondrial oxygen consumption (mitoVO2). The first panel shows an example of the oxygen
disappearance rate after local occlusion of the microcirculation. In the second panel we demonstrate the analysis of the mitochondrial oxygen tension
(mitoPO2), the green line represents the linear fit (ΔPO2(t)/Δt) of the oxygen disappearance rate. B. The mitoVO2 are presented in a box-and-whiskers graph.
The boxes extend from the 25th percentile to the 75th percentile, with a line at the median, the whiskers extend above and below the box to show the highest
and lowest values. Presented data are measured with two different probe temperatures (34°C and 40°C, respectively).C. Frequency distribution of all ratio
differences of the mitoVO2 at 34°C and 40°C.
doi:10.1371/journal.pone.0159544.g003
Fig 4. Correlation plot of the initial mitochondrial oxygen tension (mitoPO2) and the mitochondrial oxygen consumption (mitoVO2) at
34°C (A) and 40°C (B).
doi:10.1371/journal.pone.0159544.g004
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and oxygen consumption in human skin. The PpIX-TSLT appears to be a feasible and safe
non-invasive measurement tool that allows performing a functional optical biopsy in intact
skin.
Following topical application of ALA on the skin above the sternum, after 5 h we could
detect delayed fluorescence signals, of which the lifetime kinetics could be analyzed in 27 of the
30 healthy volunteers. Three volunteers were excluded from the analysis because the SNR was
insufficient; this was caused by technical problems with the light source at the time of measure-
ment (laser output unstable and with reduced intensity). Mean mitoPO2 values were around 45
mmHg. This is slightly lower than previously measured in rats [24, 26] and is probably
explained by inter-species differences, as well as differences in the fractional inspired oxygen
concentration (FiO2). The FiO2 in rats was 0.40 versus an atmospheric FiO2 in healthy
volunteers.
An intra-person variation in mitoPO2 was observed during the mitoPO2 measurements.
Small movements of the measuring probe relative to the skin can lead to changes in mitoPO2
due to the small measurement volume in a heterogenic tissue surface. Therefore, our group is
currently working on a measuring probe with revised optics to increase the detection area on
the skin. Combined with the ability to be placed flat on the skin and be affixed above the mea-
suring spot, this improved probe is expected to substantially reduce the intra-individual varia-
tion in mitoPO2 readings.
In this first set of human mitoVO2 measurements, under stop flow conditions, we chose to
calculate the oxygen consumption by a simple fit of the ΔPO2/Δt curve. This resulted in a
mitoVO2 of around 6 mmHg s
-1
. The measured values for mitoVO2 in human sternal skin are
comparable to the results reported for the abdominal skin of rats [23, 26], i.e. 5.8 ± 2.3 mmHg
s-1 and 5.0 ± 0.3 mmHg s-1 respectively.
The mitoVO2 measurements were performed with a heated measurement probe at 34°C
and at 40°C. Although increased oxygen consumption was expected at a higher skin tempera-
ture, no significant difference was observed in these experiments.
Fig 4 demonstrated a correlation between mitoVO2 and initial mitoPO2. This finding is
likely due to the used method for analysis of the oxygen disappearance rate, which assumes the
measuring volume to be oxygen-tight. However, oxygen diffusion into the measuring volume
during an ODR measurement increases at lower mitoPO2 and causes the deflection point and
deviation from linearity at low mitoPO2. A disadvantage of the used linear fit procedure is that
it is dependent on the deflection point. At low initial oxygen levels the deflection point has a
greater influence on the fitting procedure and gives rise to the correlation between mitoVO2
and initial PO2. This limitation might be solved by using a different analysis method for the
oxygen disappearance rate, which takes oxygen back diffusion into account [24, 34]. Although
this more complex method of analyzing has been evaluated for use in rats [24], it has yet to be
validated for use in humans; therefore, for the present study, we chose to use the more straight-
forward linear fit procedure.
The PpIX-TSLT is a novel noninvasive measurement tool that might be of considerable ben-
efit in emergency, intensive care and peri-operative medicine. For example, mitoPO2 measure-
ments could be useful to optimize oxygenation or hemodynamic status, or to guide treatment
in critically ill patients [21]. PpIX-TSLT provides a new tool for mitochondrial research but
does have some limitations. For example, unlike ex vivo respirometry, currently it cannot mea-
sure quantitatively the bioenergetic state of mitochondria and examine the different states of
mitochondrial respiration. Also, measurements in the skin might not be representative of all
other tissues in the body. Furthermore, although mitochondria in some tissues (like cardiac
muscle) consume approximately 90% of oxygen [35] it is important to recognize that mito-
chondria are not the sole consumers of oxygen. In this respect it is important to note that in rat
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skin we found cyanide to be a very effective blocker of oxygen consumption within the measur-
ing volume [23]. Assessment of mitochondrial respiration in vivo is also possible by dynamic
near-infrared spectroscopy. In contrast to PpIX-TSLT, NIRS is measured in muscle and results
have been demonstrated to correlate with respirometry in muscle biopsies (9). However, NIRS
appears somewhat more cumbersome to use for clinical monitoring because of the need for cal-
ibration and the use of blood-pressure cuffs.
This study is the first to demonstrate that measurement of mitochondrial parameters by
PpIX-TSLT is feasible in humans. Although the technique still needs further development and
optimization, the prototype allows evaluation in humans and the clinical setting. Therefore, we
conclude that the method itself is feasible to measure mitoPO2 and mitoVO2 in humans. A fol-
low-up study comparing PpIX-TSLT to other mitochondrial function measurements remains
to be performed, but use of PpIX-TSLT in pre-clinical studies showed promising results in the
fields of sepsis and transfusion medicine [26, 36] We expect that clinical implementation of the
PpIX-TSLT will make a valuable contribution to our knowledge on mitochondrial function
and oxygen metabolism under healthy and pathophysiological circumstances. For example,
this technique could be a useful tool to evaluate topical skin treatment, for guidance of systemic
mitochondrial therapy, and to monitor mitochondrial function in critically ill patients.
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